622 related articles for article (PubMed ID: 19883824)
1. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F
Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824
[TBL] [Abstract][Full Text] [Related]
2. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
Briganti A; Chun FK; Salonia A; Gallina A; Zanni G; Scattoni V; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
Urology; 2007 Jan; 69(1):147-51. PubMed ID: 17270638
[TBL] [Abstract][Full Text] [Related]
3. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Sagalowsky A; Bensalah K; Raman JD; Bolenz C; Kassou W; Koppie TM; Wood CG; Wheat J; Langner C; Ng CK; Capitanio U; Bertini R; Fernández MI; Mikami S; Isida M; Ströbel P; Montorsi F
Eur Urol; 2009 Sep; 56(3):512-8. PubMed ID: 19559518
[TBL] [Abstract][Full Text] [Related]
4. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
[TBL] [Abstract][Full Text] [Related]
5. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
[TBL] [Abstract][Full Text] [Related]
6. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
[TBL] [Abstract][Full Text] [Related]
7. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
Xylinas E; Rink M; Margulis V; Faison T; Comploj E; Novara G; Raman JD; Lotan Y; Guillonneau B; Weizer A; Pycha A; Scherr DS; Seitz C; Sun M; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Gönen M; Shariat SF;
J Urol; 2013 Feb; 189(2):468-73. PubMed ID: 23253960
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.
Roscigno M; Cozzarini C; Bertini R; Scattoni V; Freschi M; Da Pozzo LF; Briganti A; Gallina A; Capitanio U; Colombo R; Giorgio G; Montorsi F; Rigatti P
Eur Urol; 2008 Apr; 53(4):794-802. PubMed ID: 18207313
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
10. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
Seitz C; Gupta A; Shariat SF; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Otto W; Tritschler S; Bastian PJ; Carballido J; Ficarra V; Karakiewicz PI; Artibani W; Mazzoleni G; Novara G
J Urol; 2010 Nov; 184(5):1895-900. PubMed ID: 20846680
[TBL] [Abstract][Full Text] [Related]
11. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
Urology; 2007 Feb; 69(2):265-9. PubMed ID: 17320661
[TBL] [Abstract][Full Text] [Related]
12. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
[TBL] [Abstract][Full Text] [Related]
13. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience.
Mason RJ; Kassouf W; Bell DG; Lacombe L; Kapoor A; Jacobsen N; Fairey A; Izawa J; Black P; Tanguay S; Chin J; So A; Lattouf JB; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Fradet Y; Rendon RA
Urology; 2012 Apr; 79(4):840-5. PubMed ID: 22365453
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
15. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
[TBL] [Abstract][Full Text] [Related]
16. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
[TBL] [Abstract][Full Text] [Related]
17. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study.
Xylinas E; Kluth L; Rieken M; Rouprêt M; Al Hussein Al Awamlh B; Clozel T; Sun M; Karakiewicz PI; Gonen M; Shariat SF
Urol Oncol; 2017 Jan; 35(1):33.e21-33.e26. PubMed ID: 27816402
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
19. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
[TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
